ID27599A - JOINTS THAT CONTAIN THE VALUE OF TREATMENT FROM ESTROGEN RECEPTOR MODULATORS (SERM) AND SERRETAGOGUE SECRETAGOGUE OF GROWTH HORMONES (GHS) FOR TREATMENT OF AUTOMATIC FRAMEWORK FRAMEWORK (SERM) - Google Patents

JOINTS THAT CONTAIN THE VALUE OF TREATMENT FROM ESTROGEN RECEPTOR MODULATORS (SERM) AND SERRETAGOGUE SECRETAGOGUE OF GROWTH HORMONES (GHS) FOR TREATMENT OF AUTOMATIC FRAMEWORK FRAMEWORK (SERM)

Info

Publication number
ID27599A
ID27599A IDW20002627A ID20002627A ID27599A ID 27599 A ID27599 A ID 27599A ID W20002627 A IDW20002627 A ID W20002627A ID 20002627 A ID20002627 A ID 20002627A ID 27599 A ID27599 A ID 27599A
Authority
ID
Indonesia
Prior art keywords
serm
treatment
framework
serretagogue
ghs
Prior art date
Application number
IDW20002627A
Other languages
Indonesian (id)
Inventor
Hua Zhu Ke
Mei Li
Lydia Codetta Pan
David Duane Thompson
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Publication of ID27599A publication Critical patent/ID27599A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
IDW20002627A 1998-06-16 1999-06-16 JOINTS THAT CONTAIN THE VALUE OF TREATMENT FROM ESTROGEN RECEPTOR MODULATORS (SERM) AND SERRETAGOGUE SECRETAGOGUE OF GROWTH HORMONES (GHS) FOR TREATMENT OF AUTOMATIC FRAMEWORK FRAMEWORK (SERM) ID27599A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US8946998P 1998-06-16 1998-06-16

Publications (1)

Publication Number Publication Date
ID27599A true ID27599A (en) 2001-04-12

Family

ID=22217825

Family Applications (1)

Application Number Title Priority Date Filing Date
IDW20002627A ID27599A (en) 1998-06-16 1999-06-16 JOINTS THAT CONTAIN THE VALUE OF TREATMENT FROM ESTROGEN RECEPTOR MODULATORS (SERM) AND SERRETAGOGUE SECRETAGOGUE OF GROWTH HORMONES (GHS) FOR TREATMENT OF AUTOMATIC FRAMEWORK FRAMEWORK (SERM)

Country Status (30)

Country Link
EP (1) EP1087764A1 (en)
JP (1) JP2002518326A (en)
KR (1) KR20010052852A (en)
CN (1) CN1301160A (en)
AP (1) AP9901582A0 (en)
AR (1) AR018869A1 (en)
AU (1) AU4054799A (en)
BG (1) BG105041A (en)
BR (1) BR9911324A (en)
CA (1) CA2335134A1 (en)
CO (1) CO5070587A1 (en)
EA (1) EA200001186A1 (en)
GT (1) GT199900087A (en)
HN (1) HN1999000097A (en)
HR (1) HRP20000859A2 (en)
HU (1) HUP0102505A3 (en)
ID (1) ID27599A (en)
IL (1) IL138630A0 (en)
IS (1) IS5691A (en)
MA (1) MA26652A1 (en)
NO (1) NO20006312L (en)
OA (1) OA11505A (en)
PA (1) PA8475901A1 (en)
PE (1) PE20000646A1 (en)
PL (1) PL344981A1 (en)
SK (1) SK18912000A3 (en)
TN (1) TNSN99124A1 (en)
TR (1) TR200003544T2 (en)
WO (1) WO1999065486A1 (en)
ZA (1) ZA993975B (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2653300A (en) * 1999-02-08 2000-08-29 Mcgill University Non-human transgenic animal whose germ cells and somatic cells contain a knockout mutation in dna encoding orphan nuclear receptor erralpha
EP1156120B1 (en) 2000-05-08 2006-11-22 Pfizer Products Inc. Enzymatic resolution of selective estrogen receptor modulators
BR0113626A (en) * 2000-08-30 2003-06-17 Pfizer Prod Inc Sustained-Release Formulations for Growth Hormone Secretors
IL145106A0 (en) * 2000-08-30 2002-06-30 Pfizer Prod Inc Intermittent administration of a geowth hormone secretagogue
US7476653B2 (en) 2003-06-18 2009-01-13 Tranzyme Pharma, Inc. Macrocyclic modulators of the ghrelin receptor
WO2006024931A2 (en) * 2004-08-31 2006-03-09 Pfizer Products Inc. Therapeutic combinations comprising a selective estrogen receptor modulator and a selective androgen receptor modulator
CU23558A1 (en) 2006-02-28 2010-07-20 Ct Ingenieria Genetica Biotech COMPOUNDS ANALOG TO THE PEPTIDIC SECRETAGOGS OF THE GROWTH HORMONE
EP2644618B1 (en) 2007-02-09 2016-08-17 Ocera Therapeutics, Inc. tether intermediates for the synthesis of macrocyclic ghrelin receptor modulators

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UA51676C2 (en) * 1995-11-02 2002-12-16 Пфайзер Інк. (-)cis-6(S)-phenyl-5(R)-[4-(2-pyrrolidin-I-ylethoxy)phenyl]-5,6,7,8-tetrahydronaphthalen-2-ol D-tartrate, a method of its preparation, method of THE treatment OF diseases medicated by agonists of estrogen and a pharmaceutical composition
TW432073B (en) * 1995-12-28 2001-05-01 Pfizer Pyrazolopyridine compounds
HN1996000101A (en) * 1996-02-28 1997-06-26 Inc Pfizer COMBINED THERAPY FOR OSTEOPOROSIS

Also Published As

Publication number Publication date
PE20000646A1 (en) 2000-08-05
BG105041A (en) 2001-08-31
ZA993975B (en) 2000-12-15
JP2002518326A (en) 2002-06-25
TNSN99124A1 (en) 2005-11-10
KR20010052852A (en) 2001-06-25
OA11505A (en) 2004-05-07
PA8475901A1 (en) 2000-05-24
PL344981A1 (en) 2001-11-19
HUP0102505A2 (en) 2001-11-28
IL138630A0 (en) 2001-10-31
HRP20000859A2 (en) 2001-04-30
CN1301160A (en) 2001-06-27
CO5070587A1 (en) 2001-08-28
GT199900087A (en) 2000-12-07
WO1999065486A1 (en) 1999-12-23
NO20006312D0 (en) 2000-12-12
EA200001186A1 (en) 2001-06-25
HUP0102505A3 (en) 2002-12-28
AR018869A1 (en) 2001-12-12
SK18912000A3 (en) 2001-10-08
BR9911324A (en) 2001-04-03
HN1999000097A (en) 1999-11-03
IS5691A (en) 2000-10-27
CA2335134A1 (en) 1999-12-23
MA26652A1 (en) 2004-12-20
NO20006312L (en) 2000-12-12
EP1087764A1 (en) 2001-04-04
AU4054799A (en) 2000-01-05
AP9901582A0 (en) 1999-06-30
TR200003544T2 (en) 2001-04-20

Similar Documents

Publication Publication Date Title
IL152384A0 (en) Modulators of receptors for parathyroid hormone and parathyroid hormone-related protein
PL320416A1 (en) Group of androstanes and pregnanes for alosteric modulation of gaba receptors
IL148046A0 (en) Bicyclic androgen and progesterone receptor modulator compounds and methods
AU8072798A (en) Method and apparatus for automatic placement of advertising
DK0741603T3 (en) Apparatus for coating solid particles
ID27599A (en) JOINTS THAT CONTAIN THE VALUE OF TREATMENT FROM ESTROGEN RECEPTOR MODULATORS (SERM) AND SERRETAGOGUE SECRETAGOGUE OF GROWTH HORMONES (GHS) FOR TREATMENT OF AUTOMATIC FRAMEWORK FRAMEWORK (SERM)
GB2326358B (en) Improved positioning device for concave of cone crusher
DK1015088T3 (en) Apparatus and method for separating a mixture of a less weighty liquid and a more weighty liquid
NO20010468D0 (en) Use of biogenic estrogen sulfamates for hormone replacement therapy
DK1034396T3 (en) Process and apparatus for shipment of super-frozen materials
DK0559333T3 (en) Fertilizer spreading apparatus
EP1567178A4 (en) Modulators of receptors for parathyrois hormone and parathyroid hormone-related protein
HUP0100502A3 (en) Device for the capillary transport of liquid
ID21569A (en) HORMONAL COMPOSITION ESTABLISHED FROM ESTROGEN COMPOUND AND PROGRESTIONAL COMPOUND
DK0868841T3 (en) Particle Spreading Device
DK0852998T3 (en) Method and apparatus for the automatic manufacture of shoes
DK0931454T3 (en) Apparatus for comminution and mixing of animal feed components
NO20006381D0 (en) Therapeutic combinations of (selective) estrogen receptor modulators (SERM) and growth hormone secretion agents
DK0824206T3 (en) Device for forced delivery of fluid
AU1330901A (en) Compounds and methods for modulating non-transcriptional effects of steroid hormones
DE29723182U1 (en) Pluggable device for adjusting the brightness of lamps
EP1414445A4 (en) Partial agonists at the glycine modulatory site of the nmda receptor for treating cognitive dysfunction
DK0900915T3 (en) Methods for the preparation and preparation of an underground fire and associated apparatus
ZA984197B (en) 1-ar(alk)ylimidazolin-2-ones for the treatment of anxiety and tension states.
EP0738902A3 (en) Procedure and apparatus for the preparation of weather satellite pictures